Skip to main content
Log in

Plasma visfatin levels in preeclamptic and normal pregnancies

Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

Increasing evidences support the participation of adipokines in the pathogenesis of preeclampsia (PE). Visfatin is a novel adipokine secreted by fat tissue and macrophages and is involved in the regulation of glucose homeostasis. Our aim is to investigate visfatin levels in women with PE, women with the third trimester of normal pregnancy and healthy non-pregnant women.

Patients and methods

We included 32 preeclamptic patients who received antenatal and obstetric care at Perinatology Clinic. A total of 32 pregnant women with normal ongoing pregnancies and 32 non-pregnant women were taken as the control groups. Plasma levels of visfatin were quantified by ELISA.

Results

Plasma levels of visfatin were 63.8 ± 4.9 ng/ml in women with PE, 43.6 ± 7.8 ng/ml in pregnant control and 31.6 ± 4.2 ng/ml in the non-pregnant control, respectively (P < 0.001). Visfatin level was significantly higher in PE compared with non-pregnant control (P < 0.001) and pregnant control (P < 0.001); also, plasma level of visfatin was significantly higher in severe PE (75.3 ± 4.6 ng/ml) than mild PE (41.8 ± 5.2 ng/ml) (P < 0.001).

Conclusion

The results of the present study indicate that women with PE had significantly increased visfatin concentrations in the third trimester. Furthermore, visfatin levels were significantly higher in severe PE group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Roberts JM, Gammil HS (2005) Preeclampsia: recent insights. Hypertension 46(6):1243–1249

    Article  CAS  PubMed  Google Scholar 

  2. Fasshauer M, Paschke R (2005) Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594–1603

    Article  Google Scholar 

  3. O’Sullivan AJ, Kriketos AD, Martin A, Brown MA (2006) Serum adinopectin levels in normal and hypertensive pregnancy. Hypertens Pregnancy 25(3):193–203

    Article  PubMed  Google Scholar 

  4. Catalano PM, Hoegh M, Minimium J, Houston-Presley L, Bernard S, Kalhan S et al (2006) Adinopectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49(7):1677–1685

    Article  CAS  PubMed  Google Scholar 

  5. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430

    Article  CAS  PubMed  Google Scholar 

  6. Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A et al (2007) Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6:363–375

    Article  CAS  PubMed  Google Scholar 

  7. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Woltz M (2006) The release of adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909–1914

    Article  CAS  PubMed  Google Scholar 

  8. Dogru T, Sonmez A, Tasci I, Bozoglu E, Yılmaz MI, Genc H et al (2007) Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 76(1):24–29

    Article  CAS  PubMed  Google Scholar 

  9. Jian WX, Luo TH, Gu YY, Zhang HL, Zheng S, Dai M et al (2006) The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet Med 23(9):967–973

    Article  CAS  PubMed  Google Scholar 

  10. Pagano C, Pilon C, Oliveri M, Mason P, Fabris R, Serra R et al (2006) Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 91(8):3165–3170

    Article  CAS  PubMed  Google Scholar 

  11. Kryzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N et al (2006) Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 110(5):605–609

    Article  Google Scholar 

  12. Akturk M, Altinova AE, Mert I, Buyukkagnıcı U, Sargın A, Arslan M et al (2008) Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Invest 31:610–613

    CAS  PubMed  Google Scholar 

  13. Mazaki-Tovi S, Romero R, Kusanovic JR, Vaisbuch E, Erez O, Than NG et al (2009) Maternal visfatin concentration in normal pregnancy J Perinat Med 37:206–217

    CAS  Google Scholar 

  14. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J et al (2008) Serum levels of adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol 69:69–73

    Article  CAS  Google Scholar 

  15. Hu W, Wang Z, Wang H, Huang H, Dong M (2008) Serum visfatin levels in late pregnancy and pre-eclampsia. Acta Obstet Gynecol 87:413–418

    Article  CAS  Google Scholar 

  16. Report of National High Blood Pressure Education ProgramWorking Group (2000) Report of high blood pressure in pregnancy. Am J Obstet Gynecol 183:1–22

    Google Scholar 

  17. Fasshauer M, Blüher M, Stumvoll M, Tönessen P, Faber R, Stepan H (2007) Differential regulation of visfatin and adinopectin in pregnancies with normal and abnormal placental function. Clin Endocrinol 66:434–439

    Article  CAS  Google Scholar 

  18. Adali E, Yildizhan R, Kolusari A, Kurdoglu M, Bugdayci G, Sahin HG et al (2009) Increased visfatin and leptin in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med 1:1–7

    Google Scholar 

  19. Ramsay JE, Jamieson N, Greer IA, Satar N (2003) Paradoxical elevation in adinopectin concentrations in women with preeclampsia. Hypertension 42:891–894

    Article  CAS  PubMed  Google Scholar 

  20. Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA (2006) Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab 290:326–333

    Article  Google Scholar 

  21. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J et al (2003) Adinopectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301:1045–1050

    Article  CAS  PubMed  Google Scholar 

  22. Haider DG, Schindler K, Schaller G, Prager G, Woltz M, Ludvik B (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gatric banding. J Clin Endocrinol Metab 91:1578–1581

    Article  CAS  PubMed  Google Scholar 

  23. Kryzanowska K, Mittermayer F, Krugluger W, Kopp HP, Schernthaner G (2006) Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity 14:1886–1889

    Article  Google Scholar 

  24. Ognjanovic S, Bryant-Greenwood GD (2002) Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 187:1051–1058

    Article  CAS  PubMed  Google Scholar 

  25. Malamitsi-Puchner A, Briana DD, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D (2007) Blood visfatin concentrations in normal full-term pregnancies. Acta Pediatr 96:526–529

    Article  Google Scholar 

  26. Malamitsi-Puchner A, Briana DD, Boutsikou M, Kouskouni E, Hassiakos D, Gourgiotis D (2007) Perinatal circulating levels in intrauterine growth restriction. Pediatrics 119:1314–1318

    Article  Google Scholar 

Download references

Conflict of interest stetement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ebru Zulfıkaroglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zulfıkaroglu, E., Isman, F., Payaslı, A. et al. Plasma visfatin levels in preeclamptic and normal pregnancies. Arch Gynecol Obstet 281, 995–998 (2010). https://doi.org/10.1007/s00404-009-1192-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-1192-z

Keywords

Navigation